Skip to main content

Table 2 Medical history and functional outcome according to MSTS score

From: Is total femoral replacement for non-oncologic and oncologic indications a safe procedure in limb preservation surgery? A single center experience of 22 cases

Patient number

Group/diagnosis

Initial reconstruction

Indication for TFR

Number of revisions prior to TFR

Age at reconstruction

MSTS score

General criteria

Limb-specific criteria

Score

Pain

Function

General acceptance

Supports

Walking ability

Gait

1

Group A: oncologic patients

OSa

DFR

Mechanical failure

0

62

4

3

4

3

5

4

23

2

OSa

PFR

Periprosthetic fracture

1

31

5

3

1

5

5

3

22

3

OSa

DFR

Mechanical failure

7

44

4

3

3

4

3

3

20

4

OSa

DFR

Mechanical failure

2

34

5

4

4

4

5

3

25

5

OSa

DFR

Aseptic loosening

0

40

3

3

2

5

4

3

20

6

OSa

DFR

Mechanical failure

4

33

3

2

5

5

5

2

22

7

CSa

DFR

Aseptic loosening

0

33

4

3

5

5

4

2

23

8

CSa

HP

Recurrence tumor

0

76

4

2

3

0

3

2

14

9

M

Nail

Metastasis

0

71

0

1

1

0

0

1

3

10

Group B: patients with failed arthroplasty

HP

Periprosthetic fracture

2

64

4

3

3

0

3

1

14

11

HP and KP

Periprosthetic fracture

7

70

2

2

4

0

3

2

13

12

KP

Aseptic loosening

1

84

0

1

0

0

2

1

4

13

KP

Periprosthetic fracture

8

86

1

0

0

0

0

0

1

14

DFR

Periprosthetic fracture

0

74

1

1

0

2

3

1

8

15

Nail

Periprosthetic fracture

4

90

4

0

1

0

1

0

6

16

HP and KP

Periprosthetic fracture

1

79

1

1

3

0

2

1

8

17

KP

Periprosthetic fracture

2

70

3

2

3

0

4

3

15

18

DFR

Periprosthetic fracture

2

85

1

1

0

0

2

1

5

19

PFR

Periprosthetic fracture

0

88

4

0

3

0

0

0

7

20

HP

Septic loosening

1

70

2

1

3

0

2

1

9

21

HP

Periprosthetic fracture

2

83

2

2

4

1

3

3

15

22

HP and KP

Periprosthetic fracture

3

77

4

1

2

0

2

1

10

All patients

Mean

2.1

65.6

2.8

1.8

2.5

1.5

2.8

1.7

13

Standard deviation

2.5

20.2

1.6

1.2

1.6

2.1

1.6

1.2

7

Group A

Mean

1.6

47.1

3.5

2.6

3.0

3.5

3.6

2.4

18.6

Standard deviation

2.5

17.7

1.6

0.9

1.6

2.2

1.7

0.7

7.1

Group B

Mean

2.5

78.5

2.1

1.0

1.9

0.3

2.0

1.2

8.4

Standard deviation

2.5

8.3

1.4

0.7

1.6

0.6

1.2

1.0

4.3

  1. MSTS Musculoskeletal Tumor Society, OSa osteosarcoma, CSa chondrosarcoma, M metastasis, HP hip prosthesis, KP knee prosthesis, DFR distal femoral replacement, PFR proximal femoral replacement, TFR total femoral replacement